These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27826644)

  • 1. Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury.
    Kanbay M; Vervloet M; Cozzolino M; Siriopol D; Covic A; Goldsmith D; Solak Y
    Calcif Tissue Int; 2017 Mar; 100(3):217-228. PubMed ID: 27826644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation regulates fibroblast growth factor 23 production.
    Francis C; David V
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):325-32. PubMed ID: 27191351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 and acute kidney injury.
    Neyra JA; Moe OW; Hu MC
    Pediatr Nephrol; 2015 Nov; 30(11):1909-18. PubMed ID: 25480729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease.
    Babitt JL; Sitara D
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):304-310. PubMed ID: 31145704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
    David V; Martin A; Isakova T; Spaulding C; Qi L; Ramirez V; Zumbrennen-Bullough KB; Sun CC; Lin HY; Babitt JL; Wolf M
    Kidney Int; 2016 Jan; 89(1):135-46. PubMed ID: 26535997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 and the heart.
    Faul C
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):369-75. PubMed ID: 22531163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin suppresses the production of fibroblast growth factor 23 (FGF23).
    Bär L; Feger M; Fajol A; Klotz LO; Zeng S; Lang F; Hocher B; Föller M
    Proc Natl Acad Sci U S A; 2018 May; 115(22):5804-5809. PubMed ID: 29760049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
    Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay.
    Rousseau AF; Souberbielle JC; Delanaye P; Damas P; Cavalier E
    Burns; 2016 Aug; 42(5):1082-1087. PubMed ID: 27215149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bone at the intersection of kidney and heart disease.
    Campos I; Faul C
    Trends Pharmacol Sci; 2022 Feb; 43(2):84-86. PubMed ID: 34865884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
    Grabner A; Schramm K; Silswal N; Hendrix M; Yanucil C; Czaya B; Singh S; Wolf M; Hermann S; Stypmann J; Di Marco GS; Brand M; Wacker MJ; Faul C
    Sci Rep; 2017 May; 7(1):1993. PubMed ID: 28512310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin-2: a novel link between the injured kidney and the bone.
    Courbon G; David V
    Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):312-319. PubMed ID: 35727169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
    Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
    Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
    Wolf M; Koch TA; Bregman DB
    J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 4: the missing link between chronic kidney disease and FGF23-induced left ventricular hypertrophy?
    Wyatt CM; Drüeke TB
    Kidney Int; 2016 Jan; 89(1):7-9. PubMed ID: 26759036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23 in chronic kidney disease.
    Wahl P; Wolf M
    Adv Exp Med Biol; 2012; 728():107-25. PubMed ID: 22396166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute blood loss stimulates fibroblast growth factor 23 production.
    Rabadi S; Udo I; Leaf DE; Waikar SS; Christov M
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F132-F139. PubMed ID: 28877877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney.
    Simic P; Kim W; Zhou W; Pierce KA; Chang W; Sykes DB; Aziz NB; Elmariah S; Ngo D; Pajevic PD; Govea N; Kestenbaum BR; de Boer IH; Cheng Z; Christov M; Chun J; Leaf DE; Waikar SS; Tager AM; Gerszten RE; Thadhani RI; Clish CB; Jüppner H; Wein MN; Rhee EP
    J Clin Invest; 2020 Mar; 130(3):1513-1526. PubMed ID: 32065590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of FGF23: Beyond Bone.
    Simic P; Babitt JL
    Curr Osteoporos Rep; 2021 Dec; 19(6):563-573. PubMed ID: 34757587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.